Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response

BACKGROUND: Locoregional therapy combined with systemic therapy can further improve the prognoses for HCC. However, the efficacy of TACE combined with ICIs and TKIs for HCC and whether this triple therapy can activate systemic immune response are still unknown. PURPOSE: To identify the efficacy of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fei, Xu, Gui-Li, Huang, Jin-Tao, Yin, Yu, Xiang, Wei, Zhong, Bin-Yan, Li, Wan-Ci, Shen, Jian, Zhang, Shuai, Yang, Jun, Sun, Hong Peng, Wang, Wan-Sheng, Zhu, Xiao-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922415/
https://www.ncbi.nlm.nih.gov/pubmed/35300339
http://dx.doi.org/10.3389/fimmu.2022.847601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922415/
https://www.ncbi.nlm.nih.gov/pubmed/35300339
http://dx.doi.org/10.3389/fimmu.2022.847601

Ejemplares similares